Detrimental effect of the combination of R164S with G238S in TEM-1 β-lactamase on the extended-spectrum activity conferred by each single mutation

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 1, 2000, Pages 101-104

  Giakkoupi, P ^a,b   Tzelepi, E ^b   Tassios, P T ^a   Legakis, N J ^a   Tzouvelekis, L S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFPROZIL; CEFTAZIDIME; CLAVULANIC ACID; PENICILLIN G; TAZOBACTAM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; ESCHERICHIA COLI; MUTANT; PLASMID; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED;

EID: 0033965873     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Amyes, S. G. B. (1998). Genes and spectrum: the theoretical limits. Clinical Infectious Diseases 27, Suppl. 1, 21-8.
2. Knox, J. R. (1995). Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrobial Agents and Chemotherapy 39, 2593-601.
3. Chanal, C., Poupart, M.-C., Sirot, D., Labia, R., Sirot, J. & Cluzel, R. (1992). Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 β-lactamase genes. Antimicrobial Agents and Chemotherapy 36, 1817-20.
4. Du Bois, S. K., Marriott, M. S. & Amyes, S. G. (1995). TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. Journal of Antimicrobial Chemotherapy 35, 7-22.
5. Blazquez, J., Morosini, M. I., Negri, M. C., Gonzaiez-Leiza, M. & Baquero, F. (1995). Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM β-lactamases. Antimicrobial Agents and Chemotherapy 39, 145-9.
6. Nelson, R. M. & Long, G. L. (1989). A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Analytical Biochemistry 180, 147-51.
7. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A3. NCCLS, Villanova, PA.
8. Giakkoupi, P., Miriagou, V., Gazouli, M., Tzelepi, E., Legakis, N. J. & Tzouvelekis, L. S. (1998). Properties of mutant SHV-5 β-lactamases constructed by substitution of isoleucine or valine for methionine at position 69. Antimicrobial Agents and Chemotherapy 42, 1281-3.
9. Tzouvelekis, L. S., Gazouli, M., Prinarakis, E. E., Tzelepi, E. & Legakis, N. J. (1997). Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against β-lactamases that belong to groups 1, 2b and 2be. Antimicrobial Agents and Chemotherapy 41, 475-7.
10. Matagne, A., Lamotte-Brasseur, J. & Frere, J.-M. (1998). Catalytic properties of class A β-lactamases: efficiency and diversity. Biochemical Journal 330, 581-98.